Create differentiated solutions for nutraceuticals, medical applications, animals, dermo-cosmetics, personal care, oral care and hair care.
Domains
Health and care brands are looking for ingredients that combine proven efficacy, regulatory acceptability, sustainability, consumer-friendly positioning and reliable supply.
KitOzyme's fungal chitosan platform was developed to answer these challenges.
EFSA, FDA, and national health authorities are raising the bar on substantiation. A health claim without a clinical dossier is no longer a competitive advantage, it is a liability. Formulators need ingredients that come with the evidence already built in.
Vegan, clean label, allergen-free and sustainably sourced are from now on baseline expectations across nutraceuticals, dermo-cosmetics, and medical nutrition. Animal-derived ingredients are under growing pressure from both consumers and certification bodies. KitOzyme’s ingredients are designed to meet these expectations while preserving the performance your formulation demands.
Consistency, traceability, and independence from volatile sourcing are now procurement criteria as much as price. Formulators are looking for partners who manufacture in Europe, control their own production, and guarantee batch-to-batch quality.
These three shifts converge on the same requirement: an ingredient platform that is scientifically documented, non-animal, and industrially reliable.
From a single fungal biopolymer platform, we develop targeted solutions for diverse applications across health, nutrition, and personal care.
Our brands
Create differentiated solutions for nutraceuticals, medical applications, veterinary health, dermo-cosmetics, personal care, oral care and hair care.
Fungal chitosan ingredients for skin care, dermo-cosmetics, sun, cleansing and make-up.
Fungal chitosan grades for hair care, styling, conditioning and protection.
Where Nature Meets Oral Care Innovation
Where innovation meets wound care and hemostasis.
Feed-approved fungal chitosan for animal health and nutrition
our mushroom chitosan holds an EFSA-approved health claim for fat binding and an FDA GRAS classification, two of the most demanding regulatory benchmarks in the industry.
our fungal Chitin-Glucan, a biopolymer we discovered and patented, is approved as a Novel Food in the EU and supported by clinical evidence in gut health and cardiovascular markers.
our fungal chitosan derivatives are certified by ECOCERT GREENLIFE and compliant with the COSMOS standard to cover skin, hair, oral care, wound care and sun protection with a single non-animal biopolymer platform.
our manufacturing operates under ISO 13485, the quality standard that wound care and hemostatic applications require.
One platform.
Multiple regulatory frameworks.
A single partner.
Supporting your development with science.
KitOzyme combines scientific expertise, application testing, field trials and regulatory support to help accelerate your product development.
Available upon request
Find clear, science-backed answers to common questions about our fungal biopolymers, applications, regulatory compliance, and formulation integration.
All questionsYes. KitOzyme’s key ingredients are supported by peer-reviewed clinical studies, preclinical research, and regulatory dossiers adapted to each application and market. KiOnutrime® holds an EFSA-approved health claim and FDA GRAS classification. KiOtransine® is supported by scientific research in gut health and microbiota modulation. KitOderm™ derivatives are supported by studies on film formation, bioadhesion, and antimicrobial activity. The full publication library is available on request.
Yes. All KitOzyme’s health and care ingredients are derived from fungi and mushrooms, non-animal in origin and free from animal by-products at every stage of production. They are compatible with vegan, halal, and kosher formulation requirements. KitOderm™ derivatives are additionally verified by ECOCERT GREENLIFE and compliant with the COSMOS standard.
KitOzyme’s Health & Care platform covers nutraceuticals (cardiometabolic health, weight management, and gut health), skin health and dermo-cosmetics, hair and scalp care, oral health, wound care and hemostasis, sun and UV protection, and animal health and nutrition. Each application is supported by a dedicated brand, a documented body of scientific evidence, and a clear regulatory pathway.
Fungal chitosan is a cationic biopolymer extracted from the cell walls of fungi, at KitOzyme, from Aspergillus niger mycelium and Agaricus bisporus. Its unique functional properties to include film formation, bioadhesion, lipid binding, antimicrobial activity, and biocompatibility, make it relevant across a wide range of health and care applications. Unlike conventional chitosan derived from crustacean shells, it is non-animal, allergen-free, and compatible with vegan, halal, and kosher formulation requirements.
KitOzyme’s fungal and mushroom chitosan hold an EFSA-approved health claim for fat binding and FDA GRAS classification. Fungal chitin-glucan holds Novel Food status in the European Union. KitOzyme’s chitosan derivatives are verified by ECOCERT GREENLIFE and compliant with the COSMOS standard. Manufacturing is conducted under ISO 13485 and HACCP quality systems. Application-specific regulatory documentation is available on request.
All KitOzyme ingredients are manufactured in Herstal, Belgium, through controlled industrial processes under ISO 13485 and HACCP quality systems. European manufacturing guarantees full supply chain traceability, consistent batch-to-batch quality, and independence from Asian sourcing, a strategic advantage for formulators prioritizing supply chain reliability.
Fungal biopolymers offer a non-animal, allergen-free, and sustainably produced alternative to crustacean-derived chitosan and synthetic polymers, without compromising functional performance. They are produced from renewable fungal biomass, manufactured in Belgium under strict quality systems, and supported by internationally recognized regulatory approvals including EFSA health claim, FDA GRAS status, and Novel Food authorization in the EU.
